M/s Ind-Swift Laboratories has set up a facility for manufacture of APIs: Quetiapine Fumarate, Ropinirole HCI, Aripiprazole, Clopidogrel Besylate, Risedronate Sodium, Venlafaxine HCI, Donepezil, Nateglinide and Fluvastatin sodium. The company has made significant improvement in the existing processes for all the 9 APIs. The modified processes result in products with enhanced purity and yield. The production of APIs in the facility has commenced.